Metraipolis › archive › dc_fc353d501b0c

Therapeutic Drug Monitoring Versus Fixed-Interval Dosing of Dalbavancin in Implant-Associated Spinal Infections: Grand Round/A Case Study — Europe PMC PMID:40970606

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40970606
DOI
10.1097/ftd.0000000000001386
License (as archived)
solo-consultazione
Archived
2026-11-09T21:07:48.966Z
SHA-256 of the archived text
9d3e71e7dd4bbf434b76008ba8c102ec72d0a48d6960d4a14244406dae853c72
Stable URL of this page
https://metraipolis.com/documento/dc_fc353d501b0c

How to cite

Therapeutic Drug Monitoring Versus Fixed-Interval Dosing of Dalbavancin in Implant-Associated Spinal Infections: Grand Round/A Case Study — Europe PMC PMID:40970606 — Europe PMC (en), https://europepmc.org/article/MED/40970606 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fc353d501b0c (Metraipolis archive dc_fc353d501b0c, sha256 9d3e71e7dd4bbf434b76008ba8c102ec72d0a48d6960d4a14244406dae853c72)
BibTeX
@misc{dcfc353d501b0c,
  title = {Therapeutic Drug Monitoring Versus Fixed-Interval Dosing of Dalbavancin in Implant-Associated Spinal Infections: Grand Round/A Case Study — Europe PMC PMID:40970606},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40970606},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fc353d501b0c; sha256 9d3e71e7dd4bbf434b76008ba8c102ec72d0a48d6960d4a14244406dae853c72},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40970606. Agents can read the archived copy with the MCP tool read_document.